Design Therapeutics (DSGN) Balance Sheet: Assets & Liabilities

Design Therapeutics (DSGN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Design Therapeutics reported total assets of $226.20M and total liabilities of $13.70M. Shareholders' equity was $212.50M, down 12.2% from $242.10M a year earlier. Total debt stood at $1.53M against $219.84M in cash and short-term investments, a net cash position of $218.31M. That puts debt-to-equity at 0.01, compared with 0.01 a year earlier.

Design Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Design Therapeutics, Inc. (DSGN) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	16.86	22.56	21.20	26.50	298.57	2.38	0.08
Short-Term Investments	202.99	222.91	260.60	303.89	85.50	33.71	0.00
Cash & Short-Term Investments	219.85	245.48	281.80	330.39	384.06	36.09	0.08
Accounts Receivable	1.68	1.26	1.43	1.12	0.11	0.01	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.26	1.30	2.79	3.62	0.01	0.13	0.01
Total Current Assets	223.78	248.04	284.58	335.12	385.44	36.23	0.09
Non-Current Assets
Property, Plant & Equipment (Net)	2.42	3.63	4.63	5.56	5.12	0.07	0.00
Other Non-Current Assets	0.00	0.43	0.43	0.46	0.00	0.21	0.00
Total Non-Current Assets	2.42	4.05	5.06	6.02	5.12	0.28	0.00
Total Assets	226.20	252.09	289.64	341.14	390.56	36.52	0.09
Current Liabilities
Accounts Payable	2.31	2.19	1.94	3.03	1.62	1.40	2.48
Short-Term Debt	0.89	1.60	1.43	1.28	0.49	0.00	0.70
Accrued Liabilities	10.74	1.90	2.93	3.57	1.02	0.93	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.20
Other Current Liabilities	9.85	4.68	6.25	6.47	3.17	0.93	0.36
Total Current Liabilities	13.06	8.46	9.62	10.78	5.28	2.33	3.73
Non-Current Liabilities
Long-Term Debt	0.65	1.53	2.33	3.05	3.14	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	-2.33	-3.05	0.00	45.50	0.00
Total Non-Current Liabilities	0.65	1.53	2.33	3.05	3.14	45.50	0.00
Total Liabilities	13.70	10.00	11.96	13.83	8.43	47.83	3.73
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.01	0.00	0.00
Retained Earnings	-297.01	-227.21	-177.63	-110.76	-47.46	-11.92	-3.64
Accumulated Other Comprehensive Income	0.40	0.48	0.06	-3.36	-0.24	0.16	0.00
Additional Paid-in Capital	509.10	468.83	455.25	441.42	429.82	-44.91	0.00
Shares Outstanding	60.40	56.75	56.47	55.90	55.44	-	-
Total Stockholders' Equity	212.50	242.10	277.69	327.31	382.13	-11.32	-3.64
Total Liabilities & Equity	226.20	252.09	289.64	341.14	390.56	36.52	0.09

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Design Therapeutics Balance Sheet

How much debt does Design Therapeutics have?

Design Therapeutics had total debt of $1.53M as of Dec 31, 2025, against $219.84M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was $3.13M a year earlier.

What are Design Therapeutics's total assets?

Design Therapeutics reported total assets of $226.20M as of Dec 31, 2025, down 10.3% from $252.09M a year earlier. Total liabilities were $13.70M.

What is Design Therapeutics's shareholders' equity?

Design Therapeutics's shareholders' equity was $212.50M as of Dec 31, 2025, or about $3.52 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition